Scientific Advisory Board

Max Planck Institutes are assessed by an independent scientific advisory board on a regular basis to ensure consistent, high-quality research. The board members are selected by the president of the Max Planck Society in the light of suggestions from the institute, for a maximum term of six years.

The scientific advisory board of the Max Planck Institute for Medical Research currently includes eight members.


Prof. Dr. Rudolf Glockshuber
ETH Zürich, Department of Biology, Institute for Molecular Biology and Biophysics

Prof. Dr. Itaru Hamachi
Kyoto University, Institute for Integrated Cell-Material Sciences

Prof. Dr. Ehud Isacoff
University of California, Department of Molecular and Cell Biology

Prof. Dr. Clemens Kaminski
University of Cambridge, Department of Chemical Engineering and Biotechnology

Prof. Dr. Josef A. Käs
University of Leipzig, Soft Matter Physics Division Biophysics

Prof. Alanna Schepartz
Yale University, Department of Chemistry

Prof. Dr. Ben Schuler
Universität Zürich, Department of Biochemistry

Prof. Dr. Janet Smith
University of Michigan, Life Sciences Institute

Prof. Dr. Lydia Sorokin
Westfälische Wilhelms-Universität Münster, Institute for Physiological Chemistry and Pathobiochemistry

Prof. Dr. Shimon Weiss
University of California, Department of Chemistry and Biochemistry

loading content
Go to Editor View